Abstract Title:

Fish oil supplementation decreases serum soluble receptor activator of nuclear factor-kappa B ligand/osteoprotegerin ratio in female patients with rheumatoid arthritis.

Abstract Source:

Clin Biochem. 2009 Dec 21. PMID: 20034487

Abstract Author(s):

Sousan Kolahi, Amir Ghorbanihaghjo, Samira Alizadeh, Nadereh Rashtchizadeh, Hassan Argani, Ali-Reza Khabazzi, Mehrzad Hajialilo, Elham Bahreini

Abstract:

Objective: Soluble receptor activator of nuclear factor-kappa B ligand (sRANKL) to osteoprotegerin ratio is designated as a bone metabolism equation in many rheumatologic disorders and would be modified with Fish Oil (FO) supplementation. Design and Methods: Eighty three females with rheumatoid arthritis were divided randomly to 40 and 43 patients treated with (1g/day) or without FO for 3 months accompanied with conventional drugs, respectively. Osteoprotegerin, sRANKL, tumor necrosis factor alpha (TNFalpha) serum levels were measured before and after treatment. Results: Serum levels of osteoprotegerin increased, although sRANKL, TNFalpha and sRANKL/osteoprotegerin ratio decreased with FO therapy. A significant positive correlation was observed between sRANKL/osteoprotegerin ratio and TNFalpha levels (r = 0.327, p = 0.040) in the FO treated group. Conclusions: FO could decrease the inflammatory response by lowering of serum TNFalpha levels and sRANKL/osteoprotegerin ratio. Copyright © 2009. Published by Elsevier Inc.

Study Type : Human Study

Print Options


Facebook Comments

GMI Comments

Login to Comment

Commenting is limited to Members only. If you are already a member, please login to post a comment. If you do not have a member account and would like to become a member, please click here to begin the process to become a member.